Original Research
Jun 12
Lisette Okkels Jensen, Evald Høj Christiansen
The SORT OUT IX trial compared a polymer-free biolimus-eluting stent with a biodegradable-polymer sirolimus-eluting stent in an all-comer PCI population. At 5 years, target lesion failure was similar, but target lesion revascularization was higher with the biolimus-eluting stent.
Original Research
Jun 11
Nicolaj Brejnholt Støttrup, Michael Maeng
A randomized trial comparing 5-year outcomes of the SYNERGY everolimus-eluting stent and the BioMatrix biolimus-eluting stent, finding comparable target lesion failure but lower myocardial infarction rates with the SYNERGY stent.
Trial Design
Jun 10
Josef Kroupa, Viktor Kocka, et al.
The PRAGUE-26 trial is a randomized, active-controlled study comparing catheter-directed thrombolysis to standard anticoagulation in patients with intermediate-high risk acute pulmonary embolism.
open access
Editorial
Jun 6
Charalambos Antoniades, Kenneth Chan
This study demonstrates that revascularizing flow-limiting coronary obstructions does not substantially reduce the risk of myocardial infarction or cardiac death in chronic coronary syndromes, and highlights the role of coronary inflammation in the natural history of atherosclerosis.
free
Original Research
Jun 5
Shota Naniwa, Hiromasa Otake, et al.
This retrospective study found that higher pericoronary adipose tissue (PCAT) attenuation on coronary CT angiography was independently associated with a higher risk of a patient-oriented composite endpoint after percutaneous coronary intervention with current-generation drug-eluting stents.
Research Correspondence
Jun 4
Alexander M. Griffioen, Keith G. Oldroyd, et al.
This content covers a range of interventional cardiology procedures, including coronary, valvular, heart failure, and peripheral interventions, and their advancements in treating various cardiovascular conditions.
Trial Design
May 28
Valeria Paradies, Pieter C. Smits, et al.
The COMPARE STEMI ONE trial will assess the non-inferiority of 1-month DAPT followed by prasugrel monotherapy versus 12-month prasugrel-based DAPT, and the superiority of OCT-guided versus angiography-guided complete revascularisation in STEMI patients undergoing PCI.
Original Research
May 28
Giuseppe Gargiulo, Giovanni Esposito, et al.
This study assessed the pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention. Cangrelor provided effective platelet inhibition, but switching to oral P2Y12 inhibitors, especially clopidogrel, exposed patients to a period of high residual platelet reactivity.
Meet Cory, your AI Assistant!
Learn more
Enhance your reading experience and get deeper insights on complex topics.
Flashlight
Jun 2
Nino Cocco, Kambis Mashayekhi, et al.
The AMAC technique, involving the use of a guide extension catheter and an anchor balloon, is presented as an alternative approach to enhance support and improve crossability and penetrability in complex PCI procedures.
Expert Consensus
Jun 3
Jens Erik Nielsen-Kudsk, Philippe Garot, et al.
This manuscript proposes a novel implanter classification system for left atrial appendage (LAA) closure, aimed at overcoming the limitations of current anatomical classifications and predicting procedural risks.
free
NEW ISSUE
Jun 2
A new left atrial appendage closure implanter classification system; measuring pericoronary adipose tissue attenuation; 5-year follow-up of the SORT OUT VIII, SORT OUT IX and IDEAL-LM trials; catheter-directed thrombolysis vs anticoagulation in pulmonary embolism; news from the EAPCI; and more
Editorial
May 28
Francesco Franchi, Claudio Laudani
The study found that concomitant use of cangrelor and oral P2Y12 inhibitors may lead to drug-drug interactions and higher rates of high residual platelet reactivity, especially when switching from cangrelor to clopidogrel.
free
Expert Review
May 27
Sunny Goel, Gilbert H.L. Tang, et al.
This review explores various leaflet modification techniques, including BASILICA, ShortCut, and UNICORN, designed to mitigate the risk of coronary obstruction during transcatheter aortic valve implantation.
Original Research
May 27
Cristina Giannini, Anna Sonia Petronio, et al.
This registry assessed the incidence of long-term structural valve deterioration (SVD) beyond 5 years post-transcatheter aortic valve implantation (TAVI). The crude incidence of moderate/severe SVD was 9.5%, with predictors including intra-annular valve, small valve size, and paravalvular leak.
Research Correspondence
May 27
Ju Hyeon Kim, Seung‐Jung Park, et al.
OCT-guided percutaneous coronary intervention (PCI) showed comparable safety and effectiveness to IVUS-guided PCI in patients with and without acute coronary syndrome (ACS), despite increased procedural complexity and contrast use with OCT.
Trending articles
Transcatheter treatment for tricuspid valve disease
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)
Management of cardiogenic shock
Aortic regurgitation: from mechanisms to management
A deep learning algorithm for detecting acute myocardial infarction
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Targeting inflammation in atherosclerosis: overview, strategy and directions
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
A new implanter classification system for left atrial appendage closure from the European Left Atrial Appendage Closure Club (ELAACC)
State-of-the-Art Review
10.4244/EIJ-D-21-00695 • Nov 19, 2021
Praz F et al
free
Expert review
10.4244/EIJ-D-21-00690 • May 15, 2022
Moroni F et al
free
Clinical research
10.4244/EIJ-D-23-00312 • Sep 18, 2023
Werner G et al
free
State-of-the-Art Review
10.4244/EIJ-D-20-01296 • Aug 27, 2021
Thiele H et al
free
State-of-the-Art
10.4244/EIJ-D-23-00840 • Sep 2, 2024
Baumbach A et al
free
Clinical research
10.4244/EIJ-D-20-01155 • Oct 20, 2021
Liu W et al
free
CLINICAL RESEARCH
10.4244/EIJ-D-17-00381 • Oct 11, 2017
Foin N et al
free
State-of-the-Art
10.4244/EIJ-D-23-00606 • Jan 1, 2024
Waksman R et al
free
Original Research
10.4244/EIJ-D-25-00331 • May 21, 2025
Jang Y et al
open access
Expert consensus
10.4244/EIJ-D-24-00954 • Jun 2, 2025
Nielsen-Kudsk J et al
free
